Malignant multiple sclerosis: clinical and demographic prognostic factors

Area of Science:

• Neurology
• Immunology
• Clinical Medicine

Background:

• Malignant multiple sclerosis (MMS) is a rare, rapidly progressing form of the disease.
• MMS leads to significant disability within five years, often reaching an Expanded Disability Status Scale score of 6.
• Understanding the clinical characteristics of MMS is crucial for early diagnosis and management.

Purpose of the Study:

• To analyze the clinical profile and disease progression in a Brazilian cohort of patients with malignant multiple sclerosis.
• To identify potential prognostic factors differentiating MMS from typical multiple sclerosis.
• To inform therapeutic decisions by understanding the characteristics of aggressive multiple sclerosis.

Main Methods:

• Retrospective analysis of a Brazilian cohort of 293 multiple sclerosis patients.
• Identification of 25 patients (8.53%) diagnosed with MMS.
• Comparison of demographic and clinical features between the MMS group and the non-MMS group (268 patients).

Main Results:

• Malignant multiple sclerosis patients were more frequently women, non-white, and older at disease onset.
• Shorter intervals between initial attacks and a higher number of attacks within the first two years were observed in the MMS group.
• These clinical and demographic factors were significantly more common in patients with malignant multiple sclerosis.

Conclusions:

• Specific patient demographics and early disease characteristics are associated with malignant multiple sclerosis.
• Identifying these factors can aid in predicting a more aggressive disease trajectory.
• These prognostic indicators are valuable for guiding early and intensive therapeutic strategies in multiple sclerosis management.